Electroconvulsive therapy triggered Takotsubo cardiomyopathy in a patient despite long-term beta-adrenergic receptor blockade.
Case Report (n=1)
Highlights the risk of developing Takotsubo cardiomyopathy following electroconvulsive therapy even in patients on beta-blockers.
Treatment of patients with severe depressive illnesses requiring electroconvulsive therapy (ECT) is challenging. This is compounded by the presence of physical comorbidities and potential complications. We report the case of a patient, on long-term bisoprolol, who developed acute epigastric pain and dyspnoea shortly after receiving ECT for treatment-refractory depression. An ECG showed new-onset ischaemic changes and a troponin-I level was elevated at 12 h. A diagnosis of Takotsubo cardiomyopathy was reached following angiography, which demonstrated left ventricular hypokinesia in the absence of coronary artery disease. With supportive treatment the patient made a good recovery. This report highlights the risk of developing Takotsubo cardiomyopathy following ECT despite β-adrenergic receptor blockade, and adds to a growing number of cases reporting this complication. Clinicians involved in the care of patients undergoing ECT must be aware of this complication and should consider Takotsubo cardiomyopathy in patients who develop atypical chest pain after ECT.
Narayanan et al. (Tue,) conducted a case report in Treatment-refractory depression (n=1). Electroconvulsive therapy was evaluated on Takotsubo cardiomyopathy. Electroconvulsive therapy triggered Takotsubo cardiomyopathy in a patient despite long-term beta-adrenergic receptor blockade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: